Merck Announces Promising Long-Term Results of Pimicotinib in Phase 3 MANEUVER Trial for TGCT Treatment Merck, a leading global science and technology company, has today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial. This pivotal…
Satellos Bioscience Inc., a clinical-stage biotechnology company dedicated to developing transformative therapies for degenerative muscle diseases, announced today that it will present two scientific posters at the upcoming 30th Annual Congress of the World Muscle Society (WMS), scheduled to take…
ReCode Therapeutics, a clinical-stage genetic medicines company pioneering tissue-specific delivery technologies to advance the next generation of mRNA and gene correction therapeutics, announced today that it has secured more than $29 million in new financing. Alongside this financial update, the…
Exploring Hydrogen Water in Psychological Treatment Echo is shining a spotlight on peer-reviewed research that suggests hydrogen-rich water may have a supportive role in psychological care. The study, recently published in Health Psychology Research, examined how hydrogen water could enhance…
Amplitude Vascular Systems (AVS), a medical device company pioneering solutions to safely and effectively treat severely calcified arterial disease, today announced the opening of its new global headquarters at 180 Third Avenue in Waltham, Massachusetts. The state-of-the-art facility spans 37,811…
ConcertAI’s TeraRecon, a leading provider of AI-powered advanced visualization (AV) and clinical workflow solutions, today announced it has surpassed 2,000 global customers. This milestone underscores the continued acceleration of TeraRecon’s cloud-first SaaS transformation, reflecting strong adoption across clinical imaging domains…
Marginum, a Finnish medical technology company, has reached a major milestone with the announcement that its flagship device, HIVEN®, has been cleared for the CE mark under the European Union’s Medical Device Regulation (MDR). This certification, achieved in just over…
PQE Group is proud to announce that its U.S. subsidiary, PQE US, Inc., has been named the “Best Life Sciences Company in Maryland” by the prestigious Stellar Business Awards. This recognition highlights PQE’s leadership, innovation, and commitment to excellence within…
Teledyne Labtech and Bangor University Pioneer Welsh Space Cooling Project Teledyne Labtech, a global leader in advanced electronic printed circuit board (PCB) solutions, is spearheading an ambitious Welsh-led initiative that could transform the way spacecraft manage heat in the unforgiving…
Pi Health, a global health technology and clinical research company, today announced a strategic collaboration with GSK to deliver fully outsourced clinical research services. The partnership aims to meaningfully improve the speed and efficiency of the clinical trial process. Under…
Summit Therapeutics Inc. announced that data from the Phase III HARMONi-6 trial will be highlighted during the prestigious Presidential Symposium at the upcoming European Society for Medical Oncology (ESMO) Congress 2025, taking place in Berlin, Germany, from October 17–21, 2025.…
Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, announced today two major milestones that significantly advance its lead gene therapy program for dysferlinopathy, a rare and debilitating neuromuscular disease. The company has secured a commitment of…